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berrant activation of the Wnt/
 
 
 
-catenin signaling
pathway is associated with numerous human cancers
and often correlates with the overexpression or
ampliﬁcation of the 
 
c-myc
 
 oncogene. Paradoxical to the
cellular transformation potential of c-Myc is its ability to also
induce apoptosis. Using an inducible c-MycER expression
system, we found that Wnt/
 
 
 
-catenin signaling suppressed
apoptosis by inhibiting c-Myc–induced release of cytochrome
c and caspase activation. Both cyclooxygenase 2 and
WISP-1 were identiﬁed as effectors of the Wnt-mediated
antiapoptotic signal. Soft agar assays showed that neither
 
c-Myc nor Wnt-1 alone was sufﬁcient to induce cellu-
A
 
lar transformation, but that Wnt and c-Myc coordinated
in inducing transformation. Furthermore, coexpression of
Wnt-1 and c-Myc induced high-frequency and rapid tumor
growth in nude mice. Extensive apoptotic bodies were
characteristic of c-Myc–induced tumors, but not tumors
induced by coactivation of c-Myc and Wnt-1, indicating
that the antiapoptotic function of Wnt-1 plays a critical role
in the synergetic action between c-Myc and Wnt-1. These
results elucidate the molecular mechanisms by which Wnt/
 
 
 
-catenin inhibits apoptosis and provide new insight into
Wnt signaling-mediated oncogenesis.
 
Introduction
 
The Wnt family genes encode a group of secretory glycopro-
teins that play important roles in embryogenesis, cell prolif-
eration, and specification of cell fate (Nusse and Varmus,
1992; Cadigan and Nusse, 1997; Miller et al., 1999; Peifer
and Polakis, 2000; Hartmann and Tabin, 2001; Huelsken et
al., 2001; Kawakami et al., 2001). Wnt signaling is trans-
 
duced through 
 
 
 
-catenin which is regulated by the adenoma-
tous polyposis coli (APC)*/Axin/glycogen synthase kinase
(GSK)3
 
 
 
 complex (Behrens et al., 1998; Bienz and Clevers,
2000; Polakis, 2000; Woodgett, 2001). In the absence of
 
Wnt stimulation, GSK-3
 
 
 
 constitutively phosphorylates
 
 
 
-catenin at both serine and threonine residues of the NH
 
2
 
-
terminal region (known as GSK-3
 
 
 
 consensus sites), which
is well conserved within the catenin family of proteins (Yost
et al., 1996, 1998; Ikeda et al., 1998; Polakis, 2000). The
phosphorylated 
 
 
 
-catenin is ubiquitinated and degraded
through the proteasome pathway (Aberle et al., 1997; Kitagawa
et al., 1999; Matsuzawa and Reed, 2001; Sadot et al., 2001).
In the presence of Wnt stimulation, the Frizzled receptors
and low-density lipoprotein receptor-related proteins 5 and
6 synergistically stabilize 
 
 
 
-catenin by multiple mechanisms,
resulting in the accumulation of free cytosolic 
 
 
 
-catenin (He
et al., 1997; Pinson et al., 2000; Tamai, et al., 2000; Wehrli
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et al., 2000; Bafico et al., 2001; Mao et al., 2001a,b; Sun et
al., 2001). The elevated 
 
 
 
-catenin can translocate to the nu-
cleus where it forms a complex with Tcf (T cell factor) to
stimulate the expression of Wnt-responsive genes (Behrens
et al., 1996; Korinek et al., 1997; Morin et al., 1997; Riese
et al., 1997; Hecht et al., 2000; Takemaru and Moon,
2000).
Growing evidence has demonstrated that the Wnt signal-
ing pathway is associated with tumor development and/or
progression (Gat et al., 1998; Bienz and Clevers, 2000; Pei-
fer and Polakis, 2000; Polakis, 2000). Aberrant activation of
the Wnt signaling pathway is associated with a variety of hu-
man cancers, correlating with the overexpression or amplifi-
cation of c-Myc (de la Coste et al., 1998; He et al., 1998;
Miller et al., 1999; Bienz and Clevers, 2000; Polakis, 2000;
Brown, 2001). Interestingly, c-Myc was identified as a tran-
scriptional target of the APC/
 
 
 
-catenin/Tcf pathway in colo-
rectal cancer cells (He et al., 1998), suggesting that one
way Wnt signaling functions in oncogenesis is through the
growth promoting activity of c-Myc (de la Coste et al.,
1998; Miller et al., 1999). However, because c-Myc is also
an established inducer of apoptosis, oncogenic transforma-
tion mediated by c-Myc must therefore require a survival
signal to overcome its proapoptotic activity (Amati and
Land, 1994; Hueber et al., 1997; Schreiber-Agus and De-
Pinho, 1998; Zindy et al., 1998; Cole and McMahon, 1999;
Dang, 1999; Obaya et al., 1999; Prendergast, 1999; Grandori
et al., 2000). Interestingly, it has been observed that c-Myc–
induced hepatocellular carcinoma is associated with a “sec-
ond hit” mutation in the 
 
 
 
-catenin gene, suggesting that
compensating mutations in 
 
 
 
-catenin may serve to protect
cells from apoptosis and thereby facilitate transformation (de
la Coste et al., 1998).
Apoptosis is characterized by caspase activation, condensa-
tion of the nucleus, cleavage of specific protein, and DNA
fragmentation (Wang et al., 1996, 1999a; Cryns and Yuan,
1998; Green and Reed, 1998; Wang, 2001). We and others
have shown that Wnt/
 
 
 
-catenin signaling promotes cell sur-
vival in various cell types (Morin et al., 1995; Orford et al.,
1999; Cox et al., 2000; Reya et al., 2000; Satoh et al., 2000;
Shih et al., 2000; Chen et al., 2001; Ioannidis et al., 2001;
Mukhopadhyay et al., 2001). Using an inducible expression
system, Morin et al. (1995) found that overexpression of
APC in human colorectal cancer cells suppressed cell growth
by induction of apoptosis. Orford et al. (1999) reported that
overexpression of 
 
 
 
-catenin inhibited anoikis. We found
that Wnt signaling inhibited chemotherapeutic drug-medi-
ated apoptosis by suppressing the cytochrome c release and
caspase-9 activation. Inhibition of 
 
 
 
-catenin/Tcf transcrip-
tion blocked Wnt-mediated cell survival (Chen et al., 2001).
The present study was undertaken to explore whether Wnt
signaling inhibited c-Myc–mediated apoptosis, and if so, to
define the molecular mechanism underlying this activity.
Using an inducible c-MycER expression system, we found
that the Wnt signaling potently inhibited c-Myc–mediated
apoptosis by suppressing c-Myc–induced release of cyto-
Figure 1. Wnt-1 inhibits c-Myc–induced 
apoptosis in Rat-1 cells. (A) Establishment 
of Rat-1/c-MycER/Wnt-1 cells stably 
expressing Wnt-1 and control cells 
(Rat-1/c-MycER/C). Rat-1/c-MycER cells 
were transduced with retroviruses 
encoding the Wnt-1 expression vector or 
a control vector. Cells were selected 
with neomycin (600  g/ml) for 1 wk and 
the resistant clones were pooled. The 
expression of c-MycER in both Rat-1/
c-MycER/Wnt-1 and Rat-1/c-MycER/C 
cells was confirmed with monoclonal 
antibodies against c-Myc by the Western 
blot analysis (top). HA-Wnt-1 was 
detected with monoclonal antibodies 
against HA (second panel, lane 2). The 
cell fractionations were performed as 
described previously (Shimizu et al., 
1997) and cytosolic extracts were 
probed with monoclonal antibodies 
against  -catenin (third panel). For inter-
nal controls, the blots were stripped and 
reprobed with monoclonal antibodies 
against  -tubulin. (B) The activation of 
 -catenin/Tcf-mediated transcription by 
Wnt-1. Both Rat-1/c-MycER/C cell and 
Rat-1/c-MycER/Wnt-1 cells were trans-
fected with either pTopflash or pFopflash luciferase reporter plasmid. The pRL-TK Renilla luciferase reporter was cotransfected to normalize 
transfection efficiency. The fold activation was determined by comparing pTopflash luciferase activity with pFopflash luciferase activity. The 
activation values represent triplicate samples that were counted and averaged. (C) Wnt-1 inhibited c-Myc–induced cell death. Cells were 
treated with OHT (100 nM) to activate c-Myc or the vehicle control for 48 h in a low-serum condition (1%). Cell viability was determined 
with the trypan blue exclusion assay. The assays were performed in triplicate, and the results represent the mean value from the three
independent experiments. (D) Suppression of c-Myc–induced DNA fragmentation by Wnt-1 in Rat-1 cells. The attached and detached cells 
were collected at the indicated time points following OHT treatment. DNA was isolated and separated on a 1.2% agarose gel. 
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chrome c and caspase activation. Both Cox-2 and WISP-1
were identified as effectors of the Wnt-mediated survival sig-
nal. Moreover, we found that Wnt-1 potentiated c-Myc–
mediated oncogenic transformation in vitro and in vivo by
antiapoptotic mechanisms. These results provide new in-
sight into Wnt-mediated oncogenesis.
 
Results
 
Wnt signaling inhibits c-Myc–induced apoptosis
 
To determine whether Wnt signaling inhibited c-Myc–
induced apoptosis, we utilized an established Rat-1 fibro-
blast cell line expressing the inducible c-Myc protein (Rat-1/
c-MycER) (Hueber et al., 1997). In this system, c-Myc
polypeptide is fused with a portion of the human estrogen
receptor (c-MycER), which is activated only in the presence
of the synthetic steroid 4-hydroxytamoxifen (OHT). OHT
treatment alone is not cytotoxic to cells, and activation of
c-Myc by OHT addition leads to severe apoptotic cell death
in Rat-1/c-MycER cells in low-serum condition (Hueber et
al., 1997). A Wnt-1 expression vector or control vector was
transduced into Rat-1/c-MycER cells with retroviruses, al-
lowing the whole cell population to be assessed. Both Rat-1/
c-MycER cells expressing Wnt-1 (Rat-1/c-MycER/Wnt-1)
and control cells (Rat-1/c-MycER/C) were generated and
ectopic protein expression was demonstrated by Western
blot analysis (Fig. 1 A, second panel). As predicted, expres-
sion of Wnt-1 led to an elevated cytosolic level of 
 
 
 
-catenin
(Fig. 1 A, third panel, lane 2) and activated 
 
 
 
-catenin/Tcf-
dependent transcription (Fig. 1 B). To assess Wnt-1 antiap-
optotic activity, c-Myc was induced in both control and
Wnt-1–expressing cells. In contrast to control cells, Wnt-1
expression was observed to significantly reduce c-Myc–
induced cell death (Fig. 1 C). Apoptosis is a programmed
cell death with a hallmark of DNA fragmentation (Salvesen
and Dixit, 1997; Nagata, 1999). As shown in Fig. 1 D, DNA
fragmentation analysis showed that c-Myc–induced apop-
tosis occurred in a time-dependent fashion in Rat-1/c-
MycER/C cells, but not in Rat-1/c-MycER/Wnt-1 cells,
demonstrating that Wnt-1 mediated cell survival by sup-
pressing c-Myc–induced apoptosis.
c-Myc is frequently amplified or overexpressed in epithe-
lial-derived cancers (Amati and Land, 1994; He et al., 1998;
Schreiber-Agus and DePinho, 1998). Next, we utilized rat
intestinal epithelial cells (RIE), which are widely used for the
study of oncogenic transformation, as a model to test the ac-
tivity of Wnt-1 in c-Myc–mediated apoptosis. Analogous to
Rat-1 cells, a c-Myc–inducible system was generated in RIE
cells (Fig. 2 A). Activation of c-Myc by OHT induced apop-
tosis in RIE/c-MycER cells, but not in control cells (RIE/C),
after growth factor depletion (Fig. 2 B). RIE/c-MycER cells
were infected with retroviruses encoding the Wnt-1 expres-
sion vector and a control vector, and both RIE/c-MycER/
Wnt-1 and RIE-c-MycER/C cell lines were generated after
Figure 2. Wnt-1 inhibits c-Myc–
mediated apoptosis in RIE cells. (A) 
Establishment of RIE/c-MycER cells and 
RIE/c-MycER cells expressing Wnt-1. RIE 
cells were first transduced with retrovi-
ruses encoding the c-MycER expression 
vector or a control vector and selected 
with puromycin (1.5  g/ml) for 1 wk. 
The expression of c-MycER in RIE cells 
was detected with the Western blot 
analysis (top, lane 2). Lane 1 represented 
RIE cells expressing empty control 
vector. Subsequently, RIE/c-MycER cells 
were infected with retroviruses encoding 
the Wnt-1 expression vector or a control 
vector, and selected with hygromycin 
(600  g/ml). RIE/c-MycER/Wnt-1 cells 
expressing Wnt-1 were confirmed with 
the Western blot analysis (second panel, 
lane 2). Both cell fractionations and the 
detection of  -catenin were performed 
as described in Fig. 1 A. For loading 
control, membrane was stripped and 
reprobed with monoclonal antibodies 
against  -tubulin (fourth panel). Both 
RIE/c-MycER/C and RIE/c-MycER/Wnt-1 
cells expressing c-MycER proteins were 
confirmed with monoclonal antibodies 
against c-Myc (bottom). (B) Wnt-1
inhibited c-Myc-induced cell death. 
Cells were treated with OHT (100 nM) 
or the vehicle control for 72 h in a low-
serum condition (1%). The assays were performed in triplicate, and the results represent the mean value from three independent experiments. 
(C) Wnt-1 inhibited c-Myc–induced DNA fragmentation in RIE cells. DNA fragmentation analyses were performed as described in Fig. 1 D. 
(D) Wnt-1 inhibited c-Myc–induced apoptosis in the coculture assay. RIE/c-MycER cells were cocultured with Rat-2/Wnt-1 or control cells. 
Cell treatment was performed as described in (B). Twenty  l of cell supernatants were incubated with anti-histone and -DNA antibodies for 
2 h. The reaction was measured with a microplate reader at 405 nm. 
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hygromycin selection, respectively (Fig. 2 A, second panel).
Like in Rat-1 cells, Wnt-1 expression increased the cytosolic
level of 
 
 
 
-catenin in RIE cells (Fig. 2 A, third panel, lane 2).
72 h after OHT treatment, 
 
 
 
90% of RIE/c-MycER/C cells
were dead, whereas strikingly, 
 
 
 
70% of RIE/c-MycER/
Wnt-1 cells remained viable (Fig. 2 B). DNA fragmentation
analysis confirmed that Wnt-1 inhibited c-Myc–induced
apoptosis in RIE cells (Fig. 2 C). The inhibition of c-Myc–
mediated apoptosis by Wnt-1 was also confirmed by a long-
term clonogenicity assay (unpublished data). One of critical
barriers for studying Wnt signaling is that there are no bio-
logically active forms of Wnt proteins available. To confirm
our results from Wnt-expressing RIE cells, we also applied a
paracrine coculture assay to demonstrate that Wnt antiapop-
totic activity can be conferred in a paracrine fashion (Jue et
al., 1992; Mao et al., 2001a,b). RIE/c-MycER cells were co-
cultured with Rat-2 fibroblasts secreting Wnt-1 proteins or
control cells, and c-Myc–induced apoptosis was determined
with a cell death ELISA (enzyme-linked immunosorbent as-
say). Of note, at the late stage of apoptosis, the fragmented
DNA and histones are released to the cell culture medium
and can be detected by the cell death ELISA (Chen et al.,
2001). As shown in Fig. 2 D, after OHT addition, DNA
fragmentations were significantly induced in RIE/c-MycER
cells cocultured with Rat-2 control cells, but not with Rat-2/
Wnt-1 cells, indicating that Wnt-1 could suppress c-Myc–
mediated apoptosis by a paracrine manner.
Activation of c-Myc has been found to trigger the release
of cytochrome c from mitochondria to the cytosol during
the early stage of apoptosis (Juin et al., 1999). The cytosolic
cytochrome c binds to apoptotic protease-activating factor-1
to activate caspase-9 to induce apoptosis (Wang, 2001).
Studies from caspase-9
 
 
 
/
 
 
 
 embryonic fibroblasts found
that caspase-9, an initial caspase, plays an essential role in
c-Myc–mediated apoptosis (Soengas et al., 1999). Thus, we
determined whether Wnt-1 inhibited c-Myc–induced re-
lease of cytochrome c by immunofluorescence staining as
described previously (You et al., 2001). RIE cells were uti-
lized because they had relatively flat morphology. As shown
in Fig. 3 A, untreated cells exhibited a punctate cytoplasmic
staining of cytochrome c, indicating mitochondrial localiza-
tion. After OHT induction, RIE/c-MycER/C cells had very
Figure 3. Wnt-1 inhibits the release of cytochrome 
c induced by c-Myc. (A) The cytosolic release 
of cytochrome c was inhibited by Wnt-1. RIE/
c-MycER/C and RIE/c-MycER/Wnt-1 cells were 
treated with OHT (100 nM) for 24 h and fixed with 
4% paraformaldehyde. Cells were incubated with 
primary monoclonal antibodies against cytochrome 
c and with isothiocyanate-conjugated secondary 
antibody. The results were examined and photo-
graphed under a fluorescence microscope. (B) 
Inhibition of the release of cytochrome c by the 
expression of Cox-2 and WISP-1. Cell staining was 
performed as described in A. (C) Wnt-1 suppressed 
c-Myc–induced caspase-9 activities. Cells were 
treated with OHT for 36 h The attached and 
detached cells were harvested and the whole cell 
proteins were extracted. 200  g aliquots of protein 
extracts were incubated with caspase-9 substrate 
LEHD-pNA (100  M) for 3 h at 37 C. The reaction 
was recorded with a plate reader at 405 nm. The 
results represent the average value from the three 
independent experiments. 
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diffuse staining patterns in the entire cells, indicative of the
release of cytochrome c from mitochondria to the cytosol. In
contrast, RIE/c-MycER/Wnt-1 cells retained a punctate
staining pattern, suggesting that Wnt-1 blocked the release
of cytochrome c. Consistent with this observation is the
finding that c-Myc–induced caspase-9 activities were sup-
pressed by Wnt-1 (Fig. 3 C).
Wnt family members are unable to transform cells in vitro
as measured by the soft agar assay. However, some Wnt
members can induce so-called “partial transformation” of
cultured cells, characterized by morphologic changes such as
high-density growth and an elongated refractile cell shape
(Brown et al., 1986; Wong et al., 1994; Bradley and Brown,
1995; Shimizu et al., 1997). Interestingly, the morphologic
transformation by Wnt family proteins is associated with
their ability to stabilize 
 
 
 
-catenin and tumorigenesis (Wong
et al., 1994; Bradley and Brown, 1995; Shimizu et al., 1997;
Michaelson and Leder, 2001). Additionally, some members
of Wnt family proteins such as Wnt-2 are highly expressed
in colorectal cancer and breast carcinoma (Vider et al., 1996;
Peifer and Polakis, 2000; Polakis, 2000). Thus, experiments
were performed to determine whether the morphological
transforming potential of Wnt family members was corre-
lated with their ability to inhibit c-myc–mediated apoptosis.
Transforming Wnt-2 and -3 as well as nontransforming
Wnt-4 and -5a expression vectors were transduced into Rat-
1/c-MycER cells or RIE/c-MycER cells by retroviral deliv-
ery, respectively (Fig. 4 A). Consistent with previous studies
(Wong et al., 1994; Bradley and Brown, 1995; Shimizu et
al., 1997), Wnt-2 and -3, but not Wnt-4 and -5a, caused
morphological transformation (unpublished data). By cell
fractionation analysis Wnt-2 and -3 significantly increased
levels of free cytoplasmic 
 
 
 
-catenin, whereas Wnt-4 and -5a
had a minimal effect (Fig. 4 B). Histone H1 or E-cadherin
was undetectable in the cytosolic fraction, indicating that
the cytosolic fraction was not contaminated by the nuclear
or membrane fraction (unpublished data). As shown in Fig.
4, C and D, Wnt-2 and -3 potently inhibited c-Myc–induced
apoptosis in both Rat-1/c-MycER and RIE/c-MycER cells,
respectively. Although Wnt-4 and -5a slightly increased the
level of free cytosolic 
 
 
 
-catenin, the level of induction might
not be sufficient to provide protection against c-Myc–induced
apoptosis. The results suggested that only the transforming
Wnts possessed antiapoptotic activities that correlated with
stabilized levels of 
 
 
 
-catenin. Components of the Wnt sig-
naling pathways have been found to be mutated in various
human cancers (Miller et al., 1999; Bienz and Clevers, 2000;
Peifer and Polakis, 2000; Polakis, 2000; Brown, 2001).
Common to these mutations is the accumulation of free cy-
toplasmic 
 
 
 
-catenin and the constitutive activation of
 
 
 
-catenin/Tcf-mediated transcription (Behrens et al., 1996;
Korinek et al., 1997; Morin et al., 1997; Rubinfeld et al.,
1997; de la Coste et al., 1998; Hetman et al., 2000). To
mimic the oncogenic effects of elevated 
 
 
 
-catenin, we also
determined whether the ectopic expression of 
 
 
 
-catenin
could inhibit c-Myc–induced apoptosis. RIE/c-MycER cells
Figure 4. Wnt-mediated anti-apoptosis is 
associated with an elevated level of  -catenin. (A) 
Ectopic expression of Wnt-2, -3, -4, and -5a in 
Rat-1/c-Myc-ER and RIE/c-MycER cells. Rat-1 cells 
or RIE cells were transduced with retroviruses 
encoding Wnt-2, -3, -4, or -5a or a control vector. 
The expression of Wnt was detected as described 
in Fig. 1 A. (B) Stabilization of  -catenin by Wnts. 
Cell fractionation and Western blot analyses were 
performed as described in Fig. 1 A. For the internal 
controls, the blots were stripped and reprobed with 
monoclonal antibodies against  -tubulin. (C) 
Inhibition of c-Myc–induced apoptosis by Wnts in 
Rat-1 cells. The experiments were performed as 
described in Fig. 1 C. (D) Inhibition of c-Myc–
induced apoptosis by Wnts in RIE cells. The exper-
iments were performed as described in Fig. 2 B. 
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were transduced with retroviruses encoding a mutant
 
 
 
-catenin (S37A) expression vector or a control vector (Fig.
5 A). 
 
 
 
-Catenin (S37A) has a serine to alanine point mutation
at residue 37 which cannot be phosphorylated by GSK-3
 
 
 
and subsequently cannot be degraded by the ubiquitin-pro-
teasome pathway (Chen et al., 2001). As shown, overexpres-
sion of 
 
 
 
-catenin (S37A) potently suppressed c-Myc–medi-
ated apoptosis, suggesting that Wnt-mediated survival was
dependent on 
 
 
 
-catenin (Fig. 5 B).
 
Wnt-inducible genes Cox-2 and WISP-1 suppress 
c-Myc–induced apoptosis
 
To identify the potential antiapoptotic genes induced by
Wnt/
 
 
 
-catenin signaling, Western blot analysis was per-
formed to analyze known antiapoptotic genes such as the
bcl-2 family proteins and the inhibitors of apoptosis (Duck-
ett et al., 1996; Wang et al., 1998, 1999b; Vaux and Kors-
meyer, 1999). Our analysis indicated that such genes were
not regulated by Wnt signaling. Given that Cox-2 is a known
target gene of the Wnt signaling pathway (Howe et al.,
1999; Haertel-Wiesmann et al., 2000) and has been shown
to play a functional role in colorectal cancers (Tsujii et al.,
1998), the level of Cox-2 expression was examined. Western
blot analysis and semiquantitative reverse transcription-PCR
(RT-PCR) found that the expression of Cox-2 was induced
by Wnt-1 in our model system (Fig. 6 A; unpublished data).
Overexpression of Cox-2 suppressed c-Myc–induced apop-
tosis in RIE/c-Myc cells (Fig. 6, B and C). To determine
whether Cox-2 was an antiapoptotic gene responsible for
Wnt-mediated antiapoptotic function, cells were treated
with the specific Cox-2 inhibitor NS-398 at physiologic
concentrations (Tsujii et al., 1998). As shown in Fig. 6
D, inhibition of Cox-2 activity partially aborted the Wnt-
1–mediated prosurvival function in RIE/c-MycER/Wnt-1
cells, indicating that other gene products, in addition to
Cox-2, function to suppress c-Myc–mediated apoptosis.
Figure 5.  -catenin inhibits c-Myc–
mediated apoptosis. (A) Establishment of 
RIE/c-MycER cells expressing  -catenin 
(S37A). RIE/c-mycER cells were trans-
duced with retroviruses encoding the 
HA- -catenin (S37A) expression vector 
or a control vector and selected with 
neomycin (600  g/ml) for 1 wk. The 
expression of  -catenin (S37A) was 
detected with monoclonal antibodies 
against HA (top, lane 1). For the internal 
controls, the blots were stripped and 
reprobed with monoclonal antibodies 
against  -tubulin (bottom). (B)  -Catenin 
suppressed c-myc-induced apoptosis. 
The experiments were performed as 
described in Fig. 2 B.
Figure 6. Wnt-1–inducible gene Cox-2 
suppresses c-Myc–induced apoptosis. 
(A) Induction of Cox-2 by Wnt-1. The 
whole-cell extracts were prepared and 
50  g of aliquots of proteins were 
probed with polyclonal antibodies 
against Cox-2 (top). For the internal 
controls, the blots were stripped and 
reprobed with monoclonal antibodies 
against  -tubulin. (B) Establishment of 
RIE/c-MycER cells expressing Cox-2. 
Cells were transduced with retroviruses 
encoding the human Cox-2 expression 
vector and a control vector. The ectopic 
expression of Cox-2 was detected by 
Western blot analysis. (C) Cox-2 partially 
suppressed c-Myc–induced cell death. 
Cell viability was performed as 
described in Fig. 2 B. (D) NS-398, a 
specific Cox-2 inhibitor, partially 
aborted Wnt-1–mediated antiapoptosis. 
Cells were treated with OHT and the 
indicated concentrations of NS-398. Cell 
viability was performed as described in 
Fig. 2 B. The assay was performed in 
triplicate and the results represent three 
independent experiments. 
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To explore more fully the nature of Wnt gene regulation
in our model, a gene array analysis was performed. Consis-
tent with the Western blot analysis discussed above, the array
analysis demonstrated that antiapoptotic genes such as Bcl-x
 
L
 
and Bcl-w were not regulated by Wnt-1 (Fig. 7 A). Interest-
ingly, a recently cloned Wnt/
 
 
 
-catenin target gene, WISP-1
(Pennica et al., 1998; Xu et al., 2000), was identified by this
analysis (Fig. 7 B). Previous characterization of the WISP-1
promoter showed that WISP-1 is transcriptionally induced
by Wnt-1/
 
 
 
-catenin, but is independent of Tcf-mediated
transcription (Xu et al., 2000). In addition, examination of
25 human colon adenocarcinomas revealed overexpression of
Figure 7. Wnt-1–inducible gene WISP-1 suppresses c-Myc–induced apoptosis. (A) Both Bcl-xL and Bcl-w were not induced by Wnt-1, as 
detected by the microarray chips. The total RNA was prepared from cells expressing Wnt-1 or control cells. The profile of gene expression 
was systemically analyzed with Affymetrix U94A microarray chips. (B) The gene expression of WISP-1 was induced by Wnt-1. The level of 
WISP-1 mRNA is presented as fold induction by comparing cells expressing Wnt-1 with control cells. (C) The detection of WISP-1 expression 
by RT-PCR. The total RNA was isolated and 0.5  g of total RNA from each sample was amplified by RT-PCR with specific primers for mouse 
WISP-1. The expression of GAPDH mRNA in each sample was measured as an internal control for RT-PCR. D, 1 kb DNA ladder; lane 1, 
RIE/c-MycER/C cells; lane 2, RIE/c-MycER/Wnt-1. (D) Establishment of RIE/c-MycER cells expressing WISP-1. Cells were transduced with 
retroviruses encoding the human WISP-1 expression vector and a control vector. The ectopic expression of human WISP-1 was detected with 
the specific primers for human WISP-1 by RT-PCR. Parallel amplification of GAPDH served as an internal control. D, 1 kb DNA ladder; lane 1, 
RIE/c-MycER cells expressing the control vector; lane 2, RIE-c-MycER cells expressing human WISP-1; lane 3, RIE-c-MycER cells expressing 
human WISP-1 and Cox-2. (E) WISP-1 potently suppressed c-Myc–induced cell death in RIE cells. Cell viability was performed as described 
in Fig. 2 B. (F) WISP-1 potently inhibited DNA fragmentation. Cells were treated with OHT for 48 h, and DNA fragmentation analysis was 
performed as described in Fig. 2 C. (G) WISP-1 inhibited c-Myc–induced cell death in Rat-1 cells. Rat-1 cells were transduced with retroviruses 
encoding the human WISP-1 expression vector and a control vector. The ectopic expression of human WISP-1 was confirmed as described in 
(D). Cell viability was performed as described in Fig. 1 B. (H) WISP-1 suppressed c-Myc-induced caspase-9 activation. Cells were treated with 
OHT for 36 h and the attached and detached cells were harvested. The whole cell protein extracts were prepared. The caspase-9 assay was 
performed as described in Fig. 2 D. (I) WISP-1 did not activate Akt in Rat-1 and RIE cells. The whole cell extracts were incubated with 
polyclonal antibodies against phospho-specific Akt (1:1,000). For internal controls, the blots were stripped and reprobed with polyclonal 
antibodies against Akt (1:1,000). 
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WISP-1 mRNA (Pennica et al., 1998). Because most human
colon cancers have elevated levels of 
 
 -catenin either caused
by the loss of function of APC mutations or by stabilizing
 -catenin mutations (Miller et al., 1999; Bienz and Clevers,
2000; Peifer and Polakis, 2000; Polakis, 2000), the elevated
WISP-1 mRNA expression in vivo is likely to result from en-
hanced  -catenin–mediated transcription. As shown in Fig.
7 C, RT-PCR analysis confirmed that WISP-1 was induced
by Wnt-1 in RIE cells. Similar results were obtained in Rat-1
cells (unpublished data). Because the ectopic expression of
WISP-1 has been shown to induce tumorigenesis in normal
rat kidney fibroblast cells (Xu et al., 2000), we hypothesized
that WISP-1 had an antiapoptotic function. WISP-1 was sta-
bly transduced into RIE/c-MycER cells with retroviruses.
The ectopic expression of WISP-1 was detected by RT-PCR
(Fig. 7 D). As shown in Fig. 7 E, after the addition of OHT,
 85% of RIE/c-MycER cells were dead, compared with
only 40% of the cells expressing WISP-1. The results were
also confirmed with DNA fragmentation analysis (Fig. 7 F).
Ectopic expression of WISP-1 also potently inhibited c-Myc-
induced apoptosis in Rat-1 cells (Fig. 7 G). To determine
whether Cox-2 and WISP-1 could cooperatively inhibit
c-Myc–induced apoptosis, both Cox-2 and WISP-1 were
stably coexpressed in RIE/c-MycER cells. As shown in Fig. 7,
E and F, coexpression of Cox-2 and WISP-1 more efficiently
inhibited c-Myc–induced apoptosis than either WISP-1 or
Cox-2 alone. Moreover, coexpression of Cox-2 and WISP-1
suppressed the release of cytochrome c (Fig. 3 B) and cas-
pase-9 activation (Fig. 7 H) induced by c-Myc. During the
preparation of this manuscript, Su et al. (2002) reported that
WISP-1 suppressed p53-mediated apoptosis through activa-
tion of Akt. Rat-1 or RIE cells express wild-type p53 and
earlier work demonstrated that c-Myc–mediated apoptosis,
partially dependent on p53, was inhibited by Akt (Kauff-
mann-Zeh et al., 1997). Based on these findings, we exam-
ined whether WISP-1 activated Akt in Rat-1 or RIE cells. As
shown in Fig. 7 I, overexpression of WISP-1 did not induce
Akt phosphorylation, suggesting that WISP-1–mediated an-
tiapoptosis was independent of Akt signaling in these cells.
Wnt signaling cooperates with c-Myc in oncogenic 
transformation by inhibiting apoptosis
Studies by He et al. (1998) demonstrated that the expression of
c-Myc was dependent on the APC/ -catenin/Tcf pathway in
transformed colorectal cancer cells. Because c-Myc expression
is tightly linked to the constitutive activation of  -catenin/Tcf
transcription (He et al., 1998), it is difficult to assess the bio-
logical role of Wnt-mediated prosurvival in cell transforma-
tion. In Rat-1 or RIE cells, we have been unable to detect Wnt-
1–mediated induction of c-Myc expression. Considering that
several oncogenes including Ras and Bcl-2 have been shown to
functionally cooperate with c-Myc in oncogenic transforma-
Figure 8. Wnt-1 cooperates with c-Myc in cell transformation. (A) Induction of focus formation by coexpression of Wnt-1 and c-Myc. 
RIE/c-MycER cells were transduced with retroviruses encoding the Wnt-1 expression vector or a control vector. Cells were untreated or 
treated with OHT for activation of c-Myc and selected with hygromycin (600  g/ml) for three weeks. No foci were formed in cells expressing 
Wnt-1 or c-Myc alone. c-Myc, RIE/c-MycER cells treated with OHT; Wnt-1, RIE/c-MycER/Wnt-1 cells treated with the vehicle control; 
c-Myc Wnt-1, RIE/c-MycER/Wnt-1 cells treated with OHT. (B) The photograph of colonies formed in soft agar. Both RIE/c-MycER/C cells 
and RIE/c-MycER/Wnt-1 cells (5   10
3 cells each) were plated in 0.3% agar medium over 0.6% agar medium underlayers in six-well plates. 
Three weeks after without or with the OHT induction, the plates were stained with methylthiazol tetrazolium (MTT) and photographed. 
(C) Wnt-1 coordinated with c-Myc in cell transformation. The assay was performed in triplicate and the results represent the mean values 
from three independent experiments. (D) Wnt-1 cooperated with c-Myc in cell transformation in Rat-1 cells. Both Rat-1/c-MycER/C cells 
and Rat-1/c-MycER/Wnt-1 cells (2   10
3 cells each) were used for the soft agar assay as described in (B).Inhibition of c-Myc–mediated apoptosis by Wnt | You et al. 437
tion (Land et al., 1982; Bissonnette et al., 1992; Cory et al.,
1999), an assessment was made whether Wnt-1 coordinated
with c-Myc in oncogenic transformation by inhibiting apopto-
sis. Coexpression of Wnt-1 and c-Myc together, but not alone,
induced RIE cells to form foci in a monolayer culture (Fig. 8
A). To further delineate this cooperative function, we per-
formed soft agar assays to measure anchorage-independent
growth that typically correlates with a tumorigenic phenotype
(Land et al., 1982; Orford et al., 1999). Consistent with above
focus formation assays, expression of either c-Myc or Wnt-1
alone was not sufficient to induce colony formation. In con-
trast, substantial colony formation was seen upon coexpression
of both c-Myc and Wnt-1 in RIE cells (Fig. 8, B and C). In the
Rat-1 cells, Wnt-1 expression alone could not induce forma-
tion of colonies, and activation of c-Myc had a background
level of colony formation. However, coexpression of c-Myc
and Wnt-1 produced four times more colonies in soft agar
than the induction of c-Myc alone (Fig. 8 D).
To determine whether Wnt-1 cooperated with c-Myc in tu-
mor development or progression, we injected both Rat-1/c-
MycER/C cells and Rat-1/c-MycER/Wnt-1 cells subcutane-
ously into nude mice. Animals were treated by intraperitoneal
injection of OHT or vehicle control every two days, respec-
tively. In the absence of OHT treatment, Rat-1/c-MycER/C
cells were unable to form tumors, whereas only small tumors
were observed 2 wk after injections of Rat-1/c-MycER/Wnt-1
cells, most likely resulting from leaky expression of the c-Myc
transgene. Inducible expression of c-Myc with OHT treatment
also caused small tumors to develop from Rat-1/c-MycER/C
cells. In sharp contrast, mice injected with Rat-1/c-MycER/
Wnt-1 cells had a rapid tumor growth and progression in
which tumors were visible 4–5 d after OHT stimulation
(Fig. 9 A). Western blot analysis confirmed that tumors ex-
pressed c-Myc or both c-Myc and Wnt-1, respectively (un-
published data). To investigate the molecular mechanisms
that underlie the synergetic action between c-Myc and Wnt-1,
tumors were subjected to pathological analyses. Interest-
ingly, hematoxylin-eosin staining revealed that a mass of dead
tissue was frequently present in c-Myc–induced tumors (Fig.
9 B, panel a and b), but not in c-Myc– and Wnt-1–induced
Figure 9. Wnt-1 cooperates with c-Myc to induce tumor formation and progression by inhibiting apoptosis in vivo. (A) Coexpression of 
Wnt-1 and c-Myc stimulated rapid tumor growth in nude mice. Rat-1/c-MycER/C or Rat-1/c-MycER/Wnt-1 cells were injected subcutaneously 
into the back of athymic nude mice. Animals were treated with the intraperitoneal injection of OHT or vehicle control every two days for two 
weeks. None of the nude mice injected with Rat-1/c-MycER/C developed tumors after administration of vehicle control. The experiments 
were performed twice and a total of 40 mice were used. (B) Histological examination of tumors. Tumors were dissected and subjected to HE 
staining or TUNEL assay. A mass of dead tissue (arrow) was present in the tumor derived from cells expressing c-Myc (a, low magnification; 
b, high magnification). No tissue breakdown was found in the tumor derived from cells expressing c-Myc and Wnt-1 (d, low magnification; 
e, high magnification). c, TUNEL-positive cells in the tumor derived from cells expressing c-Myc; f, TUNEL-positive cells in the tumor derived 
from cells expressing c-Myc and Wnt-1. (C) Wnt-1 inhibited c-Myc-mediated apoptosis in vivo. The sections were examined under a fluorescence 
microscope and the TUNEL-positive cells were counted and averaged from three fields per sample. The results represent average values from 
five tumors from each group.438 The Journal of Cell Biology | Volume 157, Number 3, 2002
tumors (Fig. 9, panel d and e). In addition, the deoxynucleoti-
dyl transferase-mediated dUTP nick end labeling (TUNEL )
assays found that c-Myc–induced tumors contained wide-
spread apoptotic cells (Fig. 9, B, panel c, and C). In contrast,
relatively few TUNEL-positive cells were monitored in c-Myc–
and Wnt-1–induced tumors (Fig. 9, B, panel f, and C). In
summary, these results suggest that Wnt-1 is capable of pro-
moting tumor growth and progression by inhibiting c-Myc–
induced apoptosis in vivo.
Discussion
Because c-Myc was identified as a target gene of the APC/ -
catenin/Tcf pathway, it has been hypothesized that Wnt sig-
naling may inhibit c-Myc–mediated apoptosis (Miller et al.,
1999; Peifer and Polakis, 2000; Polakis, 2000). In this report,
we provide the first proof that Wnt signaling inhibits c-Myc–
induced apoptosis and uncover two effectors of the Wnt anti-
apoptotic signal. The first is the Cox-2 gene, which is some-
what not surprising since Cox-2 was reported to maintain the
ability suppress apoptosis (Tsujii et al., 1998). The second ef-
fector is WISP-1, a novel Wnt-1/ -catenin–regulated gene.
WISP-1 was very recently reported to protect cells from p53-
mediated apoptosis, a mechanism involving the activation of
the Akt survival pathway (Su et al., 2002). Although Rat-1 and
RIE cells express wild-type p53, we were unable to detect acti-
vated Akt in these cells in response to WISP-1 signaling,
which indicates that WISP-1 functions in multiple antiapop-
totic pathways. Previously, WISP-1 was found to promote cell
growth in low serum condition and cells expressing WISP-1
developed prominent tumors in nude mice, but the mecha-
nisms of this regulation are unknown. Consistent with its anti-
apoptotic function, WISP-1 was found to promote c-Myc–
mediated cell transformation (unpublished data). Considering
that WISP-1 is highly expressed in colorectal carcinoma cells
in vivo (Pennica et al., 1998; Xu et al., 2000), our results sup-
port the notion that WISP-1 is an additional gene target that
plays critical roles in tumorigenesis by regulating apoptosis.
Recently, several studies demonstrated that overexpres-
sion of  -catenin leads to accumulation and activation of
p53 tumor suppressor protein (Damalas et al., 1999,
2001). The accumulation of p53 was due to induction of
expression of an alternative reading frame (ARF) product
of the INK4A tumor suppressor locus (Damalas et al.,
2001). Overexpression of  -catenin resulted in a senes-
cence-like phenotype in normal primary mouse embryo fi-
broblasts, which was dependent on both ARF and p53
function. However, these studies did not report that apop-
tosis was induced following the induction of both ARF and
p53. The results suggested that  -catenin probably acti-
vated cell survival pathways to suppress the proapoptotic
effects of both ARF and p53 (Zindy et al., 1998). In future
studies, it will be important to determine whether WISP-1
and/or Cox-2 can inhibit ARF-mediated apoptosis.
We demonstrated here that the Wnt antiapoptotic function
promotes c-Myc–mediated oncogenic transformation in vitro
and in vivo. Considering that c-Myc is a potent activator of
apoptosis, these results may provide an explanation for high
levels of both c-Myc and  -catenin found in many human can-
cer cells, such as colorectal cancers and hepatocellular carci-
noma (Amati and Land, 1994; de la Coste et al., 1998; Miller
et al., 1999; Schreiber-Agus and DePinho, 1998; Harada et al.,
1999; Obaya et al., 1999; Bienz and Clevers, 2000). Cancer
cells with the constitutive activation of Wnt/ -catenin signal-
ing may tolerate the apoptotic function of c-Myc. Another sig-
nificant implication of our study is a rationale for the molecular
basis for loss of APC at the early stage of colon cancer (Morin et
al., 1995; Bienz and Clevers, 2000; Polakis, 2000; Shih et al.,
2000). Activation of the Wnt signaling pathway by loss of APC
function may have dual effects on cell transformation or tumor
progression. One is to promote cell growth and proliferation by
induction of the growth promoting genes such as cyclin D1
and c-Myc (He et al., 1998; Tetsu and McCormick, 1999). A
second is to provide the antiapoptotic function to suppress on-
cogenic activation-mediated apoptosis. In other words, inhibi-
tion of apoptosis by the Wnt/ -catenin signal pathway may
render cells more susceptible to the actions of oncogenes.
Materials and methods
Cell culture, plasmids, and retroviral infection
Rat-1 and RIE cell lines were maintained in DME supplemented with 10%
FBS. A retrovirus pLNCX vector encoding Wnt-1, Wnt-2, Wnt-3, Wnt-4, or
Wnt-5a, and a retrovirus pBabe-c-MycER vector were utilized in our experi-
ments, as described previously (Hueber et al., 1997; Shimizu et al., 1997). A
retrovirus pBabe vector encoding the full-length human WISP-1 cDNA was
provided by Dr. Arnold Levine (Rockefeller University, New York, NY) (Xu
et al., 2000). The human full-length Cox-2 cDNA was provided by Dr. Leslie
Crofford (The University of Michigan, Ann Arbor, MI) and subcloned into a
retrovirus pLNCX vector. To establish cell lines stably expressing Wnt pro-
tein, the high-titer retroviruses were utilized, allowing whole populations of
cells to be examined with minimal expansion in culture. Retroviruses were
generated by transfecting the retroviral constructs into 293T cells and retro-
virus-containing supernatant was collected and stored at –70 C. Cells were
infected with retroviruses in the presence of 6  g/ml polybrene. 48 h after
infection, cells were selected with puromycin (1.5  g/ml), hygromycin (600
 g/ml), or neomycin (600  g/ml) for 1 wk, respectively. The resistant clones
were pooled and confirmed by the Western blot analysis.
Cell fractionation and Western blot analysis
The cell fractionations were performed as described previously (Shimizu et
al., 1997). The proteins were separated in a 10% SDS-PAGE and trans-
ferred to PVDF membrane with a semidry transferrer apparatus (Bio-Rad
Laboratories). The membranes were probed with monoclonal antibodies
against   -catenin (1:2,000; Transduction Laboratory), c-Myc (1:1000;
Santa Cruz), or Cox-2 (1:500; Santa Cruz Biotechnology). For internal con-
trols, the blots were stripped and reprobed with monoclonal antibodies
against  -tubulin (1:7,500; Sigma-Aldrich).
Cell viability, caspase activity assay, and DNA fragmentation
Cells were untreated or treated with the synthetic steroid OHT (100 nM)
for 48–72 h. The detached and attached cells were collected and cell via-
bility was determined by trypan blue exclusion or Cell Death ELISA. To de-
termine caspase-9 activity, cells were treated as described above. Cells
were lysed in 200  l of ice cold hypotonic lysis buffer. Approximately
200- g aliquots of cell extracts were incubated with caspase-9 substrate,
LEHD-NA (CLONTECH Laboratories, Inc). The samples were assessed
with a plate reader by measuring the OD at 405 nm. To examine DNA lad-
dering, the attached and detached cells were collected at the indicated
time points after OHT treatment. DNA was isolated and separated on a
1.2% agarose gel as described previously (Wang et al., 1996).
Soft agar assay and tumor growth in vivo
To assess anchorage-independent growth, 10
3 Rat-1 cells or 5   10
3 RIE
cells were plated in 0.3% low melting point agarose/growth medium onto
six-well plates with a 0.6% agarose underlay. About 1.5 ml growth me-
dium uncontaining or containing OHT (100 nM) was added on the top of
agarose and the medium was changed every 3–4 d. To determine tumor
growth, 5   10
6 Rat-1/c-Myc/C cells or Rat-1/c-MycER/Wnt-1 cells were
injected subcutaneously into the back of 8-wk-old male nude mice
(Taconic). Animals were injected intraperitoneally with OHT (2 mg/Inhibition of c-Myc–mediated apoptosis by Wnt | You et al. 439
mouse) or vehicle control every 2 d for 2 wk, respectively. These proce-
dures were approved by the University of Michigan Committee on Use
and Care of Animals (Ann Arbor, MI).
Histology and TUNEL staining
Animals were killed by asphyxiation in a CO2 chamber. The tumors were
dissected, fixed in 10% formalin, and embedded in paraffin blocks. The
specimens were cut into 4- m thick sections and stained with hematoxylin
and eosin. For TUNEL staining, the sections were dewaxed, rehydrated,
and treated with proteinase K. The labeling was performed according to
the manufacturer’s instruction (Roche).
Immunofluorescence staining.
RIE cells were seeded in 12-well plates the day before stimulation and then
treated with OHT for 36 h. Cells were fixed with 4% paraformaldehyde
and washed with PBS. After blocking with normal goat serum for 1 h, the
cells were incubated with primary monoclonal antibodies against cyto-
chrome c for 1 h, and immunocomplexes were detected with a fluorescein
isothiocyanate-conjugated secondary antibody against mouse IgG. The re-
sults were photographed by a fluorescence microscope using a filter set for
fluorescein isothiocyanate (You et al., 2001).
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